ArticleCancer biology & therapy2016

Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.

Shanna J Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.